Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
24
24 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Maridebart cafraglutideAMG 133Phase 314 trials
Amgen · Obesity, Overweight, Obstructive Sleep Apnea
- FrexalimabSAR441344Phase 39 trials
Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
- MWN109 1Phase 36 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- HDM1005 1Phase 34 trials
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight
- rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials
Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus
- THDB0206Phase 32 trials
Tonghua Dongbao Pharmaceutical Co.,Ltd · Type 2 Diabetes, Type 1 Diabetes
- TTP399CadisegliatinPhase 32 trials
vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1
- ZimislecelFormerly known as STx-02, VX-880Phase 32 trials
Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1
- ATB-1011Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1012Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1013Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- BR1019A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- VX-017Phase 31 trial
Vertex Pharmaceuticals · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- BMF-219Phase 22 trials
Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
- SYH2069group 1, group 2Phase 22 trials
CSPC Ouyi Pharmaceutical Co., Ltd. · T2DM (Type 2 Diabetes Mellitus), Overweight or Obesity
- AcmopatideCT-868, RO7795074Phase 21 trial
Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus
- CD25Phase 21 trial
PolTREG S.A. · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, Diabetes Mellitus, Type 1
- CNP-103Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM
- SAB-142Phase 21 trial
SAb Biotherapeutics, Inc. · Type 1 Diabetes
- VX-264Phase 21 trial
Vertex Pharmaceuticals · Type 1 Diabetes
- ZT-01Phase 21 trial
Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.